A20 inactivation in ocular adnexal MALT lymphoma

Haematologica

Volumn 97, Issue 6, 2012, Pages 926-930

  Bi, Yingwen ^a,b   Zeng, Naiyan ^a   Chanudet, Estelle ^a   Huang, Yuanxue ^a   Hamoudi, Rifat A ^a   Liu, Hongxiang ^c   Dong, Gehong ^a   James Watkins, A ^a   Ley, Steven C ^d   Zou, Lifen ^b   Chen, Rongjia ^b   Zhu, Xiongzeng ^b   Du, Ming Qing ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FUDAN UNIVERSITY   (China)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

A20; ABIN; Ocular adnexal MALT lymphoma

Indexed keywords

A20 PROTEIN; ABIN1 PROTEIN; ABIN2 PROTEIN; CHEMOKINE RECEPTOR CCR2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME DELETION; CHROMOSOME MICRODISSECTION; CHROMOSOME TRANSLOCATION; COBALT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR ADNEXAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AMINO ACID SEQUENCE; BCL-ASSOCIATED DEATH PROTEIN; CASPASES; DNA-BINDING PROTEINS; EYE NEOPLASMS; FEMALE; GENE EXPRESSION; HETEROZYGOTE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; RADIATION, IONIZING; RECEPTORS, CCR2; SEQUENCE DELETION; TOLL-LIKE RECEPTOR 6; TRANSLOCATION, GENETIC;

EID: 84862134821     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.036798     Document Type: Article

References (24)

1. Du MQ. MALT lymphoma: many roads lead to nuclear factor-kappab activation. Histopathology. 2011;58(1):26-38.
2. Hamoudi RA, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, Chott A, et al. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia. 2010;24(8):1487-97.
3. Chanudet E, Ye H, Ferry J, Bacon CM, Adam P, Muller-Hermelink HK, et al. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol. 2009;217(3):420-30.
4. Kim WS, Honma K, Karnan S, Tagawa H, Kim YD, Oh YL, et al. Genome-wide arraybased comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer. 2007;46(8):776-83.
5. Honma K, Tsuzuki S, Nakagawa M, Karnan S, Aizawa Y, Kim WS, et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer. 2008;47(1):1-7.
6. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, et al. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood. 2009;113(20):4918-21.
7. Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009; 459(7247):712-6.
8. Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009;459(7247):717-21.
9. Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206(5):981-9.
10. Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood. 2009;114(12): 2467-75.
11. Chanudet E, Huang Y, Ichimura K, Dong G, Hamoudi RA, Radford J, et al. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia. 2010;24(2):483-7.
12. Verstrepen L, Carpentier I, Verhelst K, Beyaert R. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochem Pharmacol. 2009;78(2):105-14.
13. Dong G, Chanudet E, Zeng N, Appert A, Chen YW, Au WY, et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large Bcell lymphoma. Clin Cancer Res. 2011;17 (6):1440-51.
14. Oshima S, Turer EE, Callahan JA, Chai S, Advincula R, Barrera J, et al. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature. 2009;457(7231):906-9.
15. Papoutsopoulou S, Symons A, Tharmalingham T, Belich MP, Kaiser F, Kioussis D, et al. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat Immunol. 2006;7(6):606-15.
16. Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S, et al. ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol. 2004;24(12):5235-48.
17. Vereecke L, Beyaert R, Van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009;30(8):383-91.
18. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40(9):1059-61.
19. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, Balsa A, Blanco FJ, Canete JD, et al. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther. 2009;11(2):R42.
20. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41(11):1234-7.
21. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41(11):1228-33.
22. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199-204.
23. Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57(5):1382-91.
24. Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114(3):501-10.